glp 1 not eating enough No Appetite on Wegovy® or Other GLP-1s? We're Here to Help GLP-1 Diet: Why Semaglutide Alone

Bernal V et al

You should expect follow ups every 4-6 weeks where a clinician will check in on your side effects, hunger cues, weight trends, and metabolic markers, then adjust your dosing as needed

You do not need to worry about one "canceling out" the other

Novo Nordisk remains confident in the benefit-risk profile of our GLP-1 medicines, when used consistent with their indications and product labeling. Michael Jamison, a spokesperson for Eli Lilly sent a statement: Patient safety is Lillys top priority, and we actively monitor, evaluate, and report safety information for all our medicines

The absence of trial evidence does not mean the combination is unsafe or ineffective

Results for frozen shoulder vary considerably